Oncothyreon Inc. News Headlines

ONTY 
$1.8
*  
0.04
2.17%
Get ONTY Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading ONTY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Pluristem Therapeutics, Inc. (PSTI) in Focus: Stock Up 7.4% - Tale of the Tape
10/7/2014 8:44:00 AM - Zacks.com


Alexion Pharmaceuticals (ALXN) in Focus: Stock Rises 6.0% - Tale of the Tape
10/6/2014 8:44:00 AM - Zacks.com


Will Oncothyreon (ONTY) Crush Estimates at Its Next Earnings Report? - Tale of the Tape
9/16/2014 8:32:00 AM - Zacks.com


Sector Update: Health-Care Shares Lower Pre-Market
9/12/2014 8:47:10 AM - MT Newswires


Sector Update: Health Care
9/12/2014 8:46:08 AM - MT Newswires


Oncothyreon (ONTY) Slumps, Tecemotide Fails Phase I/II Study - Analyst Blog
8/20/2014 3:53:00 PM - Zacks.com


Oncothyreon (ONTY) is Oversold: Can It Recover? - Tale of the Tape
8/20/2014 9:36:24 AM - Zacks.com


Tuesday Sector Laggards: Precious Metals, Biotechnology Stocks
8/19/2014 1:50:00 PM - BNK Invest


Pre-Market Most Active for Aug 19, 2014 : NOK, JRJC, ONTY, BHP, ERIC, RDEN, BBL, AAPL, HD, TVIX, ARO, DKS
8/19/2014 8:39:58 AM - NASDAQ.com News


Array BioPharma Falls Despite Narrower-than-Expected Q4 Loss - Analyst Blog
8/15/2014 9:40:00 AM - Zacks.com


Earnings Reaction History: Oncothyreon Inc., 75.0% Follow-Through Indicator, 5.7% Sensitive
8/11/2014 11:50:11 AM - MT Newswires


Wednesday Sector Leaders: Biotechnology, Paper & Forest Products
7/23/2014 2:24:17 PM - BNK Invest


Shortage Of R&D At Big Pharma Creates Demand For Small Biotech: Joseph Pantginis
6/6/2014 1:45:00 PM - Seeking Alpha


Oncothyreon Collaborates with Celldex - Analyst Blog
5/30/2014 4:40:00 PM - Zacks.com


Healthcare Stocks Climbing in Late Trade; Celldex, Oncothyreon Partnering on Prospective Cancer Treatment
5/29/2014 3:53:26 PM - MT Newswires


Sector Update: Healthcare
5/29/2014 3:52:18 PM - MT Newswires


As Investors Laud Combination Therapies, Oncothyreon's Pipeline Could Come Into Focus
4/24/2014 10:25:00 AM - Seeking Alpha


Merck KGaA Starts Study on Tecemotide - Analyst Blog
4/8/2014 6:55:01 PM - Zacks.com


Oncothyreon Inc. (ONTY) in Focus: Stock up 6.1% - Tale of the Tape
3/20/2014 8:44:01 AM - Zacks.com


Oncothyreon (ONTY) Jumps: Stock Moves 9.9% Higher - Tale of the Tape
3/6/2014 10:46:01 AM - Zacks.com


Oncothyreon Inc. (ONTY) in Focus: Stock up 9.3% - Tale of the Tape
2/26/2014 10:18:01 AM - Zacks.com


Oncothyreon Inc. (ONTY) in Focus: Stock Up 5.2% - Tale of the Tape
12/2/2013 9:44:01 AM - Zacks.com


Investments In Targeting HER2 For The Treatment Of Cancer
10/28/2013 10:39:00 AM - Seeking Alpha


Data on Oncothyreon's ONT-380 - Analyst Blog
10/8/2013 4:27:12 PM - Zacks.com


Merck Pushes On With Failed Cancer Vaccine
9/25/2013 12:54:00 PM - Seeking Alpha